6 posts tagged by Digg
World & Business
Novo is fighting for a larger share of the obesity market as Wegovy weight-loss pill sales lift its outlook.
World & Business
Reuters reports Allison Vecchio and Terri Hart said supplements helped them, but both have commercial ties to brands.
World & Business
The Economic Times reports Novo Nordisk’s oral Wegovy and Eli Lilly’s orforglipron are expected in India in the first half of 2027, and that top officials said both products have already been submitted to Indian regulators.
Science
STAT reports a shift from promoting GLP-1 drugs as tools to address obesity as a medical issue toward a lifestyle pitch.
World & Business
Bloomberg reports that the agreement covers rights to the Swedish company’s drug-delivery technology for obesity and diabetes treatments.
Science
Novo Nordisk says the partnership aims to help its scientists bring new medicines to patients faster.
